Dasatinib Accord Healthcare

Medicinal product

(Invented) name

Dasatinib Accord Healthcare

Active substance (s)

Dazatinibas

Strength

100 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EA02, dasatinib

Marketing authorisation holder

Accord Healthcare S.L.U., Ispanija

Date of authorisation

2024-07-26

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Dazatinibas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
114687	100794	1100794	lizdinė plokštelė	N30		Receptinis	EU/1/24/1839/017	Netiekiama	-	-	No	-	-
114688	100795	1100795	lizdinė plokštelė	N56		Receptinis	EU/1/24/1839/018	Netiekiama	-	-	No	-	-
114689	100796	1100796	dalomoji lizdinė plokštelė	N30×1		Receptinis	EU/1/24/1839/019	Netiekiama	-	-	No	-	-
114690	100797	1100797	dalomoji lizdinė plokštelė	N56×1		Receptinis	EU/1/24/1839/020	Netiekiama	-	-	No	-	-
118374	104480	1104480	dalomoji lizdinė plokštelė	N10×1		Receptinis	EU/1/24/1839/029	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2024-07-26	Registruotas